Publications

Detailed Information

A Case of Erythroplasia of Queyrat Treated with Imiquimod 5% Cream and Excision

DC Field Value Language
dc.contributor.authorChoi, Jee Woong-
dc.contributor.authorChoi, Mira-
dc.contributor.authorCho, Kwang Hyun-
dc.date.accessioned2012-07-04T00:42:20Z-
dc.date.available2012-07-04T00:42:20Z-
dc.date.issued2009-11-
dc.identifier.citationANNALS OF DERMATOLOGY; Vol.21 4; 419-422ko_KR
dc.identifier.issn1013-9087-
dc.identifier.urihttps://hdl.handle.net/10371/78343-
dc.description.abstractImiquimod is a new immunomodulating agent with antitumor and antiviral properties that has been shown to be clinically effective in various kinds of skin diseases, including precancerous dermatoses. Erythroplasia of Queyrat is a carcinoma in situ that mainly occurs on the glans penis. There are several non-invasive treatment options for erythroplasia of Queyrat such as photodynamic therapy, cryosurgery and applying various kinds of topical agents. We now report a case of typical erythroplasia of Queyrat on glans penis associated with human papillomavirus type 16 infection that was treated by imiquimod 5% cream and the subsequent excision of an imiquimod-resistant penile lesion. (Ann Dermatol 21(4) 419 similar to 422, 2009)ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN DERMATOLOGICAL ASSOCko_KR
dc.subjectErythroplasia of Queyratko_KR
dc.subjectImiquimodko_KR
dc.titleA Case of Erythroplasia of Queyrat Treated with Imiquimod 5% Cream and Excisionko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor최지웅-
dc.contributor.AlternativeAuthor최미라-
dc.contributor.AlternativeAuthor조광현-
dc.citation.journaltitleANNALS OF DERMATOLOGY-
dc.description.citedreferenceMicali G, 2006, J AM ACAD DERMATOL, V55, P901, DOI 10.1016/j.jaad.2006.07.021-
dc.description.citedreferenceArlette JP, 2003, BRIT J DERMATOL, V149, P43-
dc.description.citedreferencevan Seters M, 2002, J REPROD MED, V47, P701-
dc.description.citedreferenceHemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758-
dc.description.citedreferenceMeyer T, 2001, CANCER DETECT PREV, V25, P533-
dc.description.citedreferenceWieland U, 2000, J INVEST DERMATOL, V115, P396, DOI 10.1046/j.1523-1747.2000.00069.x-
dc.description.citedreferencePerry CM, 1999, DRUGS, V58, P375-
dc.description.citedreferenceStables GI, 1999, BRIT J DERMATOL, V140, P514-
dc.description.citedreferenceMiller RL, 1999, INT J IMMUNOPHARMACO, V21, P1-
dc.description.citedreferenceKAO GF, 1986, ARCH DERMATOL, V122, P1124-
dc.description.citedreferenceMIKHAIL GR, 1980, J DERMATOL SURG ONC, V6, P1027-
dc.description.citedreferenceGRAHAM JH, 1973, CANCER, V32, P1396-
dc.description.citedreferencePETERKA ES, 1961, ARCH DERMATOL, V84, P623-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share